Choosing One Drug Over Another to Treat Blindness Could Save Medicare Billions

ANN ARBOR, Mich., June 2 — The University of Michigan issued the following news release:

If all eye doctors prescribed the less expensive of two drugs to treat two common eye diseases of older adults, taxpayer-funded Medicare plans could save $18 billion over a 10-year period, say researchers at the University of Michigan.
Further, patients with the wet form of macular degeneration or who have diabetic macular edema could keep $4.6 billion in co-pays in their wallets, and the rest of the U.S. health care system could save $29 billion in private insurance payments and other costs, according to the team led by David Hutton, assistant professor of health management and policy at the U-M School of Public Health.
The reason for the dramatic savings:
Read more: http://insurancenewsnet.com/oarticle/2014/06/03/choosing-one-drug-over-another-to-treat-blindness-could-save-medicare-billions-a-512860.html#.U48E4fldV8E
Source: Insurance News Net
On